Sleepiness comorbid to musculoskeletal pain is associated with worse quality of life and mood symptoms in a general population sample.
Fiche du document
2019
- doi: 10.5935/1984-0063.20190071
- issn: 1984-0063
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/doi/10.5935/1984-0063.20190071
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pmid/31879539
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/pissn/1984-0659
Ce document est lié à :
info:eu-repo/semantics/altIdentifier/urn/urn:nbn:ch:serval-BIB_89F21EE3E4CE4
info:eu-repo/semantics/openAccess , Copying allowed only for non-profit organizations , https://serval.unil.ch/disclaimer
Mots-clés
Disorders of Excessive Somnolence; Mood Disorders; Musculoskeletal Pain; Quality of Life.; SleepSujets proches
Life, Quality of AchesCiter ce document
C. Hirotsu et al., « Sleepiness comorbid to musculoskeletal pain is associated with worse quality of life and mood symptoms in a general population sample. », Serveur académique Lausannois, ID : 10.5935/1984-0063.20190071
Métriques
Partage / Export
Résumé
Musculoskeletal (MSK) pain and hypersomnolence (HPS) are very disabling conditions that may share some pathophysiological factors. This study aimed to evaluate the interaction between MSK pain and HPS and its association with mood symptoms, fatigue, quality of life, and both objective and subjective sleep quality. Cross-sectional study. General population based sample. 510 individuals from EPISONO cohort, São Paulo (Brazil). All participants completed questionnaires, had clinical assessment and underwent a full-night polysomnography. HPS was defined according to Epworth Sleepiness Scale while the presence of MSK pain was defined by structured questionnaire. The sample was allocated into 4 groups: control (CTRL, n=281), HPS (n=141), MSK (n=50), and both conditions (HPS+MSK, n=38). MSK pain and HPS by themselves were associated with worse mood symptoms and quality of life. However, individuals with both associated conditions (HPS+MSK) presented higher frequencies of moderate to severe depression (44.1%) and anxiety symptoms (45.7%), as well as an additional decrease in quality of life compared to the other groups. There were no differences between HPS+MSK and MSK groups in objective sleep pattern. With regard to subjective sleep, HPS+MSK presented a higher prevalence of sleep attacks and cataplexy compared to all other groups. The combination of MSK pain and HPS was associated with worse mood symptoms, quality of life and HPS-related features. This study suggests that sleepiness may be an important symptom to be investigated and treated in MSK pain-related conditions for a better quality of life.